On Oct 10, major Wall Street analysts update their ratings for $Accolade (ACCD.US)$, with price targets ranging from $5 to $8.
Morgan Stanley analyst Craig Hettenbach maintains with a hold rating, and maintains the target price at $6.
Barclays analyst Stephanie Davis maintains with a hold rating, and maintains the target price at $5.
Truist Financial analyst Jailendra Singh maintains with a buy rating, and sets the target price at $7.5.
Stephens analyst Jeffrey Garro maintains with a buy rating, and adjusts the target price from $11 to $8.
Furthermore, according to the comprehensive report, the opinions of $Accolade (ACCD.US)$'s main analysts recently are as follows:
The second quarter results echo persistent themes within the business, such as enhancing profitability alongside a moderation in revenue expansion. The projections for fiscal year 2025 have been revised, with a decrease in revenue and adjusted EBITDA estimates post-report. This adjustment is due to anticipated lower growth in PlushCare and throughout the broader business model, which consequently impacts EBITDA expectations.
The shares of Accolade are experiencing an uptick following the fiscal Q2 report, backed by sustained fiscal 2025 guidance, encouraging comments about the selling season, and clear insights into a significant Q4 increase. Although the near-term environment may present challenges for securing new employer agreements, the company's sharpened emphasis on profitable expansion is seen in a favorable light.
Here are the latest investment ratings and price targets for $Accolade (ACCD.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月10日，多家华尔街大行更新了$Accolade (ACCD.US)$的评级，目标价介于5美元至8美元。
摩根士丹利分析师Craig Hettenbach维持持有评级，维持目标价6美元。
巴克莱银行分析师Stephanie Davis维持持有评级，维持目标价5美元。
储亿银行分析师Jailendra Singh维持买入评级，目标价7.5美元。
Stephens分析师Jeffrey Garro维持买入评级，并将目标价从11美元下调至8美元。
此外，综合报道，$Accolade (ACCD.US)$近期主要分析师观点如下：
第二季度业绩反映了业务内持续的主题，如增强盈利能力以及营业收入扩张速度的减缓。2025财年的预测已经修订，营业收入减少，调整后的EBITDA估计在发报后有所下降。这一调整是由于预计PlushCare的增长和整体业务模型的放缓，进而影响了EBITDA的预期。
Accolade股票正在经历一个上涨，这是在2025财年指引的支撑下的，对销售季节的鼓励性评论以及对第四季度明显增长的清晰见解。尽管近期环境可能对获得新雇主协议带来挑战，但公司对盈利扩张的强调是带来积极看法的。
以下为今日4位分析师对$Accolade (ACCD.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
